I am a research chemist who has a PhD in organic chemistry and was a postdoctoral fellow in medicinal chemistry at Memorial Sloan-Kettering. My main interest is to develop new drugs and diagnostic agents for cancer. My research focus at Memorial Sloan-Kettering has been to design and synthesize tyrosine-kinase targeted therapeutics for leukemia and other malignancies. Additionally, I have a particular interest in developing molecular tools that can improve cancer diagnosis and therapy. These include both optical and radiolabeled probes and molecular conjugates. Also, I am interested in understanding how these molecules behave in vitro and in vivo. We use non-invasive imaging techniques like PET and SPECT to directly observe drug and radiotracer behavior in the body. With the help of like-minded fellow scientists and physicians, I hope to improve many aspects of cancer treatment by developing tools to diagnose cancer earlier and find new drugs that are effective with fewer side effects. Such lofty goals are indeed attainable in this highly collaborative environment at Memorial Sloan-Kettering Cancer Center.